Merck & Company Inc (MRK)vsOption Care Health Inc (OPCH)
MRK
Merck & Company Inc
$120.79
-3.46%
HEALTHCARE · Cap: $285.64B
OPCH
Option Care Health Inc
$20.51
+2.19%
HEALTHCARE · Cap: $3.26B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 1061% more annual revenue ($65.77B vs $5.67B). MRK leads profitability with a 13.6% profit margin vs 3.6%. OPCH appears more attractively valued with a PEG of 1.17. OPCH earns a higher WallStSmart Score of 56/100 (C).
MRK
Hold50
out of 100
Grade: D+
OPCH
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-49.3%
Fair Value
$80.88
Current Price
$120.79
$39.91 premium
Margin of Safety
-3.8%
Fair Value
$33.39
Current Price
$20.51
$12.88 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Strong operational efficiency at 38.6%
Generating 2.9B in free cash flow
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
4.9% revenue growth
Elevated debt levels
Weak financial health signals
1.3% revenue growth
3.4% earnings growth
3.6% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : OPCH
The strongest argument for OPCH centers on P/E Ratio, Price/Book. PEG of 1.17 suggests the stock is reasonably priced for its growth.
Bear Case : MRK
The primary concerns for MRK are P/E Ratio, Revenue Growth, Debt/Equity.
Bear Case : OPCH
The primary concerns for OPCH are Revenue Growth, EPS Growth, Profit Margin. Thin 3.6% margins leave little buffer for downturns.
Key Dynamics to Monitor
OPCH carries more volatility with a beta of 0.65 — expect wider price swings.
MRK is growing revenue faster at 4.9% — sustainability is the question.
MRK generates stronger free cash flow (2.9B), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - GENERAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
OPCH scores higher overall (56/100 vs 50/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Option Care Health Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Option Care Health, Inc. offers infusion services at home and at alternative sites in the United States. The company is headquartered in Bannockburn, Illinois.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?